Literature DB >> 16464535

Photobiomodulation partially rescues visual cortical neurons from cyanide-induced apoptosis.

H L Liang1, H T Whelan, J T Eells, H Meng, E Buchmann, A Lerch-Gaggl, M Wong-Riley.   

Abstract

Near-infrared light via light-emitting diode treatment has documented therapeutic effects on neurons functionally inactivated by tetrodotoxin or methanol intoxication. Light-emitting diode pretreatment also reduced potassium cyanide-induced cell death, but the mode of death via the apoptotic or necrotic pathway was unclear. The current study tested our hypothesis that light-emitting diode rescues neurons from apoptotic cell death. Primary neuronal cultures from postnatal rat visual cortex were pretreated with light-emitting diode for 10 min at a total energy density of 30 J/cm2 before exposing to potassium cyanide for 28 h. With 100 or 300 microM potassium cyanide, neurons died mainly via the apoptotic pathway, as confirmed by electron microscopy, Hoechst 33258, single-stranded DNA, Bax, and active caspase-3. In the presence of caspase inhibitor I, the percentage of apoptotic cells in 300microM potassium cyanide was significantly decreased. Light-emitting diode pretreatment reduced apoptosis from 36% to 17.9% (100 microM potassium cyanide) and from 58.9% to 39.6% (300 microM potassium cyanide), representing a 50.3% and 32.8% reduction, respectively. Light-emitting diode pretreatment significantly decreased the expression of caspase-3 elicited by potassium cyanide. It also reversed the potassium cyanide-induced increased expression of Bax and decreased expression of Bcl-2 to control levels. Moreover, light-emitting diode decreased the intensity of 5-(and -6) chloromethy-2', 7-dichlorodihydrofluorescein diacetate acetyl ester, a marker of reactive oxygen species, in neurons exposed to 300 microM potassium cyanide. These results indicate that light-emitting diode pretreatment partially protects neurons against cyanide-induced caspase-mediated apoptosis, most likely by decreasing reactive oxygen species production, down-regulating pro-apoptotic proteins and activating anti-apoptotic proteins, as well as increasing energy metabolism in neurons as reported previously.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16464535     DOI: 10.1016/j.neuroscience.2005.12.047

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  38 in total

1.  Low-level laser therapy (810 nm) protects primary cortical neurons against excitotoxicity in vitro.

Authors:  Ying-Ying Huang; Kazuya Nagata; Clark E Tedford; Michael R Hamblin
Journal:  J Biophotonics       Date:  2013-10-15       Impact factor: 3.207

2.  Pre-conditioning with low-level laser (light) therapy: light before the storm.

Authors:  Tanupriya Agrawal; Gaurav K Gupta; Vikrant Rai; James D Carroll; Michael R Hamblin
Journal:  Dose Response       Date:  2014-09-22       Impact factor: 2.658

Review 3.  Applications of photobiomodulation in hearing research: from bench to clinic.

Authors:  Jae-Hun Lee; Sehwan Kim; Jae Yun Jung; Min Young Lee
Journal:  Biomed Eng Lett       Date:  2019-06-18

Review 4.  Transcranial low level laser (light) therapy for traumatic brain injury.

Authors:  Ying-Ying Huang; Asheesh Gupta; Daniela Vecchio; Vida J Bil de Arce; Shih-Fong Huang; Weijun Xuan; Michael R Hamblin
Journal:  J Biophotonics       Date:  2012-07-17       Impact factor: 3.207

5.  Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy.

Authors:  Lucas Freitas de Freitas; Michael R Hamblin
Journal:  IEEE J Sel Top Quantum Electron       Date:  2016 May-Jun       Impact factor: 4.544

6.  Transcranial Low-Level Laser (Light) Therapy for Brain Injury.

Authors:  Connor Thunshelle; Michael R Hamblin
Journal:  Photomed Laser Surg       Date:  2016-12       Impact factor: 2.796

7.  Neuroprotective effects of near-infrared light in an in vivo model of mitochondrial optic neuropathy.

Authors:  Julio C Rojas; Jung Lee; Joseph M John; F Gonzalez-Lima
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

8.  Low-intensity light therapy: exploring the role of redox mechanisms.

Authors:  Joseph Tafur; Paul J Mills
Journal:  Photomed Laser Surg       Date:  2008-08       Impact factor: 2.796

9.  Methylene blue provides behavioral and metabolic neuroprotection against optic neuropathy.

Authors:  Julio C Rojas; Joseph M John; Jung Lee; F Gonzalez-Lima
Journal:  Neurotox Res       Date:  2009-02-24       Impact factor: 3.911

10.  Far red/near infrared light treatment promotes femoral artery collateralization in the ischemic hindlimb.

Authors:  Nicole L Lohr; James T Ninomiya; David C Warltier; Dorothée Weihrauch
Journal:  J Mol Cell Cardiol       Date:  2013-05-20       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.